AZD-8835

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP20347CAS No. ：1620576-64-8Purity：

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	1620576-64-8	Cat. No.	BCP20347
Name	AZD-8835
Synonyms	AZD 8835;AZD8835;
SMILES
Chemical Name
Formula	C22H31N9O3	M. Wt	469.55
Purity		Storage	Store at 4-8°C
Description	IC50 value: 5.7 nM (PI3Kδ), 6.2 nM (PI3Kα) Target: PI3K in vitro: AZD8835 is a orally bioavailable inhibitor of the class I (PI3K) catalytic subunit alpha (PIK3CA), with potential antineoplastic activity. PI3K alpha inhibitor AZD8835 selectively binds to and inhibits PIK3CA and its mutated forms, in the PI3K/Akt (protein kinase B)/mammalian target of rapamycin (mTOR) pathway. This results in both apoptosis and growth inhibition in PIK3CA-expressing tumor cells. By specifically targeting PIK3CA, this agent may be more efficacious and less toxic than pan-PI3K inhibitors. Dysregulation of the PI3K/Akt/mTOR pathway is often found in solid tumors and results in the promotion of tumor cell growth, survival, and resistance to chemo- and radio-therapy. PIK3CA, one of the most frequently mutated oncogenes, encodes the p110-alpha catalytic subunit of the class I PI3K. In vivo: AZD8835 shows pharmacodynamic modulation of AKT phosphorylation and near complete inhibition of tumour growth (93% tumou